1. Home
  2. ZLAB vs FULTP Comparison

ZLAB vs FULTP Comparison

Compare ZLAB & FULTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • FULTP
  • Stock Information
  • Founded
  • ZLAB 2013
  • FULTP N/A
  • Country
  • ZLAB Cayman Islands
  • FULTP United States
  • Employees
  • ZLAB N/A
  • FULTP 3400
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • FULTP Major Banks
  • Sector
  • ZLAB Health Care
  • FULTP Finance
  • Exchange
  • ZLAB Nasdaq
  • FULTP Nasdaq
  • Market Cap
  • ZLAB 3.5B
  • FULTP N/A
  • IPO Year
  • ZLAB 2017
  • FULTP N/A
  • Fundamental
  • Price
  • ZLAB $32.00
  • FULTP $18.79
  • Analyst Decision
  • ZLAB Buy
  • FULTP
  • Analyst Count
  • ZLAB 4
  • FULTP 0
  • Target Price
  • ZLAB $47.37
  • FULTP N/A
  • AVG Volume (30 Days)
  • ZLAB 1.7M
  • FULTP N/A
  • Earning Date
  • ZLAB 05-08-2025
  • FULTP N/A
  • Dividend Yield
  • ZLAB N/A
  • FULTP N/A
  • EPS Growth
  • ZLAB N/A
  • FULTP N/A
  • EPS
  • ZLAB N/A
  • FULTP N/A
  • Revenue
  • ZLAB $398,988,000.00
  • FULTP N/A
  • Revenue This Year
  • ZLAB $45.57
  • FULTP N/A
  • Revenue Next Year
  • ZLAB $47.91
  • FULTP N/A
  • P/E Ratio
  • ZLAB N/A
  • FULTP N/A
  • Revenue Growth
  • ZLAB 49.59
  • FULTP N/A
  • 52 Week Low
  • ZLAB $15.65
  • FULTP N/A
  • 52 Week High
  • ZLAB $39.77
  • FULTP N/A
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.83
  • FULTP 46.30
  • Support Level
  • ZLAB $28.34
  • FULTP $17.25
  • Resistance Level
  • ZLAB $34.59
  • FULTP $19.00
  • Average True Range (ATR)
  • ZLAB 2.12
  • FULTP 0.60
  • MACD
  • ZLAB 0.40
  • FULTP 0.08
  • Stochastic Oscillator
  • ZLAB 74.98
  • FULTP 77.00

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A

Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.

Share on Social Networks: